Search results for "Dihematoporphyrin Ether"

showing 4 items of 4 documents

Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines.

1994

For efficacy of photodynamic therapy, selective uptake and retention of photoactive substances has been postulated. Therefore, measurements were performed to find out whether the photosensitiser Photofrin® is taken up differently in malignant and non-malignant cells in vitro . In addition, the sensitivity of malignant cells and nonmalignant cells to photodynamic exposure was investigated, by quantifying viability and volume alterations of the cells. Bovine aortic endothelial cells, mouse fibroblasts and amelanotic hamster melanoma cells were suspended in a specially designed incubation chamber under controlled conditions (e.g. pH, p O 2 , p CO 2 and temperature). After establishing constant…

Cancer ResearchPathologymedicine.medical_specialtyCell Survivalmedicine.medical_treatmentCellPhotodynamic therapyBiologyFlow cytometryMiceCricetinaemedicineTumor Cells CulturedAnimalsPhotosensitizerViability assayFibroblastMelanomaCells Culturedmedicine.diagnostic_testMesocricetusFibroblastsmedicine.anatomical_structureOncologyPhotochemotherapyCell cultureCancer researchCattleDihematoporphyrin EtherEndothelium VascularPhototoxicityEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Photodynamic therapy within edematous brain tissue: Considerations on sensitizer dose and time point of laser irradiation

1996

Photosensitizer is known to spread with vasogenic edema fluid arising from a cerebral lesion (Neurosurg 33:1075-1082, 1993), which may be essential for sensitizing malignant cells outside the main tumor mass. The present experiments seek to elucidate whether resultant necrosis of perifocal brain tissue after laser irradiation follows a corresponding time pattern and whether damage depends on the photosensitizer dose. Male Wistar rats were anaesthetized with chloralhydrate for venous cannulation, craniotomy and focal cold lesion in order to induce vasogenic edema. Simultaneously, Photofrin II (PF II) was administered at a dose of 5 mg kg-1. The animals were re-anaesthetized after either 4, 1…

MalePathologymedicine.medical_specialtyTime FactorsNecrosismedicine.medical_treatmentBiophysicsBrain EdemaPhotodynamic therapyBlood–brain barrierLesionmedicineAnimalsRadiology Nuclear Medicine and imagingPhotosensitizerRats WistarCraniotomySensitizationRadiationDose-Response Relationship DrugRadiological and Ultrasound TechnologyBrain NeoplasmsChemistryRatsmedicine.anatomical_structurePhotochemotherapyDihematoporphyrin EtherLaser Therapymedicine.symptomPerfusionJournal of Photochemistry and Photobiology B: Biology
researchProduct

Kinetics of Photofrin II in perifocal brain edema.

1993

Photodynamic therapy is under intense investigation as a possible adjuvant for the treatment of malignant tumors of the central nervous system. It relies on the fact that photosensitizers are selectively taken up or retained by malignant tissue. However, most brain tumors are accompanied by substantial vasogenic edema as a consequence of blood-brain barrier disruption within the tumor, leading to extravasation and propagation of plasma constituents into the surrounding brain tissue. Systemically administered photosensitizers may enter healthy tissue together with the edema fluid, possibly leading to sensitization of tissues outside the tumor. To test this hypothesis, vasogenic edema was ind…

MalePathologymedicine.medical_specialtymedicine.medical_treatmentCentral nervous systemPhotodynamic therapyBrain EdemaCerebral edemaLesionchemistry.chemical_compoundEdemamedicineAnimalsPhotosensitizerTissue DistributionRats WistarFluorescein isothiocyanatebusiness.industryBrain Neoplasmsmedicine.diseaseExtravasationRatsCold TemperatureDisease Models Animalmedicine.anatomical_structurechemistryMicroscopy FluorescencePhotochemotherapySurgeryDihematoporphyrin EtherNeurology (clinical)medicine.symptombusinessFluorescein-5-isothiocyanateExtravasation of Diagnostic and Therapeutic MaterialsNeurosurgery
researchProduct

An in vitro model to study cellular photosensitizer uptake and photodynamic dose-response relationships of tumor cells

1993

Cellular fluorescence intensity (CFI) after incubation with varying concentrations of the photosensitizer Photofrin and the photodynamically induced dose-response relationships of hamster melanoma cells (A-MEL-3) were studied in a recently developed in vitro model. After administration of Photofrin to the extracellular serum-free medium, CFI was evaluated by flow cytometry together with constantly fluorescing latex particles used as a reference. After 5 min, 50% of maximal CFI was found, and after 60 min CFI was maximal. No further increase was obtained during the exposure to Photofrin over the incubation period of 4 h. During this plateau phase, CFI was significantly related to the concent…

Pathologymedicine.medical_specialtyCell SurvivalMelanoma ExperimentalHamsterIn Vitro TechniquesBiologyFluorescenceFlow cytometrychemistry.chemical_compoundIn vivoCricetinaeTumor Cells CulturedExtracellularmedicineAnimalsPhotosensitizerViability assayCell SizeDose-Response Relationship DrugMesocricetusmedicine.diagnostic_testGeneral MedicineFlow CytometryPhotochemotherapychemistryBiophysicsDihematoporphyrin EtherTrypan bluePhototoxicityResearch in Experimental Medicine
researchProduct